A 3D rendering of a human head with a blue background. The head is facing towards the right side of the image. On top of the head there is a white circle with a yellow dot in the center which appears to be a brain scan. The yellow dot is likely a representation of the brain scan which is a medical device used to scan the brain for abnormalities or abnormalities. The white circle is connected to the yellow dot by a thin white line which may be a sensor or a device that detects the presence of a person's brain. The image also has a blue gradient background giving it a futuristic and technological feel.
Description 
Type
Category
-
Date
2017
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![An infographic that explains the benefits of full therapeutic value for patients like Patrick. It has a blue background with white text and an illustration of Patrick in the center. The illustration is of a man with his arms crossed and a serious expression on his face. <br /><br />On the left side of the image there is a line graph that shows hours on the x-axis and the pain plasma hydromorphone level on the y-axis demonstrating that "Exalgo remained above 50% of C[?] for more than 90% of dosing interval" as compared to hydromorphone. <br /><br />The right side of the graphic has recommended instructions on how best to treat a patient like Patrick with Exalgo and also has important risk information for Exalgo.](https://oida-resources-images.azureedge.net/public/full/3d05d7df-6b4f-46b4-a36b-ee5f924ecb77.png)
![Information about NUCYNTA ER. It is titled "NUCYNTA ER: better GI tolerability than oxycodone CR in a 1-year safety study". There is a bar graph at the center of the image titled "Incidence of the treatment-emergent adverse events reported [...] treatment group in a 52-week study (osteoarthritis[...]". The x-axis values between 0 and 40. The y-axis has a number of adverse events. The graph shows that NUCYNTA ER had a lower incidence of adverse events than Oxycodone for nausea vomiting constipation dizziness and skin pruritus (itching). It shows that Oxycodone had a lower incidence of adverse events for diarrhea dry mouth somnolence and headache. They show equal values for fatigue. The bars for nausea vomiting and constipation are at the top of the graph and they are highlighted in brighter colors. An arrow points to these bars and is labeled "50% lower incidence of nausea vomiting and constipation vs. oxycodone CR". <br /><br />The image also shows a red side bar with the NUCYNTA ER logo and selected important safety information.](https://oida-resources-images.azureedge.net/public/full/bdae85ed-5038-4ac0-8738-b5232296aa03.jpg)
